Thrivent Financial for Lutherans Increases Stock Holdings in Teleflex Incorporated $TFX

Thrivent Financial for Lutherans raised its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 1,161.0% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 550,449 shares of the medical technology company’s stock after purchasing an additional 506,796 shares during the period. Thrivent Financial for Lutherans’ holdings in Teleflex were worth $67,353,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the stock. Russell Investments Group Ltd. raised its position in shares of Teleflex by 23.6% in the second quarter. Russell Investments Group Ltd. now owns 83,388 shares of the medical technology company’s stock valued at $9,870,000 after buying an additional 15,935 shares during the last quarter. Speece Thorson Capital Group Inc. grew its stake in Teleflex by 2.4% in the 2nd quarter. Speece Thorson Capital Group Inc. now owns 89,843 shares of the medical technology company’s stock worth $10,634,000 after acquiring an additional 2,096 shares during the period. Creative Planning raised its holdings in Teleflex by 76.5% in the 2nd quarter. Creative Planning now owns 10,338 shares of the medical technology company’s stock valued at $1,224,000 after acquiring an additional 4,480 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Teleflex by 113.9% during the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 58,047 shares of the medical technology company’s stock worth $7,366,000 after purchasing an additional 30,912 shares during the period. Finally, CWM LLC boosted its holdings in shares of Teleflex by 160.8% during the second quarter. CWM LLC now owns 11,904 shares of the medical technology company’s stock worth $1,409,000 after purchasing an additional 7,340 shares during the last quarter. Hedge funds and other institutional investors own 95.62% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the company. Truist Financial upped their target price on Teleflex from $120.00 to $135.00 and gave the company a “hold” rating in a research note on Thursday, December 18th. Wall Street Zen downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a research report on Monday, December 29th. Needham & Company LLC raised shares of Teleflex from a “hold” rating to a “buy” rating and set a $138.00 price target on the stock in a research note on Tuesday, January 27th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and set a $135.00 price objective on shares of Teleflex in a research note on Wednesday, December 17th. Two analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $139.00.

Teleflex Stock Performance

Shares of NYSE:TFX opened at $104.40 on Monday. The business’s 50-day simple moving average is $116.10 and its 200 day simple moving average is $119.64. The company has a market cap of $4.61 billion, a P/E ratio of -14.20, a PEG ratio of 1.36 and a beta of 0.92. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.53 and a current ratio of 2.57. Teleflex Incorporated has a one year low of $100.18 and a one year high of $184.34.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share for the quarter, topping analysts’ consensus estimates of $3.38 by $0.29. The firm had revenue of $892.90 million during the quarter, compared to analysts’ expectations of $892.79 million. Teleflex had a positive return on equity of 15.64% and a negative net margin of 10.28%.Teleflex’s quarterly revenue was up 19.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $3.49 EPS. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. On average, sell-side analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, December 15th. Stockholders of record on Friday, November 14th were paid a dividend of $0.34 per share. The ex-dividend date was Friday, November 14th. This represents a $1.36 annualized dividend and a dividend yield of 1.3%. Teleflex’s dividend payout ratio (DPR) is currently -18.50%.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.